The product of another gene, FYB, is involved in T cell receptor signaling, promoting their activation and cytokine secretion [34]; its deficiency enhances the cytotoxicity of CD8+ T cells [35], and its high expression is an unfavorable marker of T cell lymphoma [36]. This evidence concerns the gene CD8A and T-cell non-Hodgkin lymphoma.